Related Experiment Video
Updated: May 1, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Emerging roles of mitochondria ROS in atherosclerotic lesions: causation or association?
Abstract:
Mitochondrial-derived reactive oxygen species (mtROS) is one of the major sources of cellular ROS, and excessive mtROS is associated with atherosclerosis progression in both human and mouse models. This review aims to summarize the most recent studies showing the existence, the causes and pathological consequences of excessive mtROS in atherosclerosis. Despite numerous association and causation studies demonstrating the importance of mtROS in atherosclerosis progression, the failure of antioxidant therapy in human randomized clinical trials demands more definitive, cell-type specific investigations. Better mechanistic understanding of mtROS in atherosclerosis may lead to more effective therapeutic strategies.
Insights
Mitochondrial reactive oxygen species (mtROS) contribute to atherosclerosis. Further cell-specific research is needed to develop effective therapies, as antioxidant treatments have failed in human trials.
Area of Science:
- Cardiovascular Research
- Mitochondrial Biology
- Oxidative Stress
Background:
- Mitochondrial-derived reactive oxygen species (mtROS) are a significant source of cellular oxidative stress.
- Excessive mtROS levels are implicated in the progression of atherosclerosis in both human and animal models.
Purpose of the Study:
- To review recent studies on the role of excessive mtROS in atherosclerosis.
- To explore the origins, pathological consequences, and therapeutic implications of mtROS in cardiovascular disease.
Main Methods:
- Literature review of recent scientific studies.
- Analysis of association and causation studies on mtROS and atherosclerosis.
- Examination of human randomized clinical trial outcomes for antioxidant therapies.
Main Results:
- Evidence supports a significant role for mtROS in atherosclerosis development and progression.
- Previous antioxidant therapies targeting ROS have shown limited success in human trials.
- Current research highlights the need for cell-type specific investigations into mtROS mechanisms.
Conclusions:
- Excessive mtROS is a key factor in atherosclerosis pathogenesis.
- The failure of broad antioxidant therapies underscores the need for targeted strategies.
- Further mechanistic studies focusing on specific cell types are crucial for developing effective treatments for atherosclerosis.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Mitochondria
Mitochondrial Membranes
Inflammation

